The Food and Drug Administration wants industry input into data needs and modeling scenarios to better understand emergency blood supply situations in an epidemic or pandemic, or other events that could affect the blood supply.

The agency on July 24 will host a day-long public workshop, titled “Use of Computer Simulation of the United States Blood Supply in Support of Planning for Emergency Preparedness and Medical Countermeasures.”

Presentation and panel discussions will cover simulation modeling of the blood supply to support planning for potential disruptions, using other simulation methods to plan daily needs and forecasting of future donations and demands, assessing capabilities and limitations of simulations, describe and prioritize future simulation enhancements to extend the model to other blood components, and assess a simulation model to develop other scenarios for addressing shortage countermeasures.

The FDA notice, published May 24 in the Federal Register, is available here.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access